The Special Medical Physics Consult Process for Reirradiation Patients
- PMID: 31681862
- PMCID: PMC6817723
- DOI: 10.1016/j.adro.2019.05.007
The Special Medical Physics Consult Process for Reirradiation Patients
Abstract
Purpose: To present a systematic approach to the reirradiation special medical physics consult (ReRT-SMPC) process.
Materials and methods: An in-house reirradiation committee of physicians and physicists was formed to develop a streamlined and well-documented approach to ReRT-SMPCs. Dosimetric goals and considerations for tissue repair were generated by the committee with input from the literature, clinical trial guidelines, and physician experience. Procedural workflow was also defined.
Results: The total number of ReRT-SMPCs performed in our department in 2018 was 401, corresponding to 369 unique patients and 16% of the total number of patients receiving external beam radiation in our department that year. This constituted a large increase over the 183 ReRT-SMPCs performed in 2017. We have found that a standardized ReRT-SMPC workflow helps to safeguard patients, documents the clinical decision-making process for medical and legal purposes, and facilitates the peer-review process. The data being collected from each consult along with toxicity and outcomes data can be used to help inform future re-treatment guidelines.
Conclusions: As the number of patients returning for additional courses of radiation continues to increase, a uniform method for the ReRT-SMPC workflow and analysis is a powerful tool for ensuring patient safety, understanding and predicting treatment toxicity, and refining reirradiation dosimetric limits.
© 2019 The Author(s).
Figures
References
-
- Bryant A.K., Banegas M.P., Martinez M.E., Mell L.K., Murphy J.D. Trends in radiation therapy among cancer survivors in the United States, 2000-2030. Cancer Epidemiol Biomarkers Prev. 2017;26:963–970. - PubMed
-
- American Cancer Society . American Cancer Society; Atlanta, GA: 2016. Cancer Treatment & Survivorship Facts & Figures, 2016-2017.
-
- von der Grün J., Köhn J., Loutfi-Krauss B., Blanck O., Rödel C., Balermpas P. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max) of >180 Gy for patients with recurrent head and neck cancer. Head Neck. 2019;41:E48–E54. - PubMed
-
- Navarria P., Minniti G., Clerici E. Re-irradiation for recurrent glioma: Outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) J Neurooncol. 2019;142:59–67. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials